2023年4月17日~2023年4月23日の間に収集した論文情報を追加しました。(2/4)
①PD-1/PD-L1 inhibitors-associated cardiac adverse events: a retrospective and real-world study based on the FDA Adverse Event Reporting System (FAERS).
PD-1およびPD-L1阻害剤による心疾患系有害事象の評価研究
対象DB:FAERS
②Association between methotrexate-induced Stevens-Johnson syndrome/toxic epidermal necrolysis and furosemide: a real-world disproportionality analysis.
フロセミドとメトトレキサートを併用した場合の、SJSおよびTENの関連性評価研究
③High risks adverse events associated with trastuzumab emtansine and trastuzumab deruxtecan for the treatment of HER2-positive/mutated malignancies: a pharmacovigilance study based on the FAERS database.
T-DM1およびT-DXdの有害事象リスク評価研究
④Propofol-associated serious adverse events: an analysis of the FAERS database.
プロポフォールの有害事象リスク評価研究
⑤Medications affecting the IGF-1/Growth Hormone Axis, including teprotumumab, somatostatin analogues and anti-CGRP monoclonal antibodies, are associated with an elevated reporting odds of alopecia in women; a pharmacovigilance study.
ソマトスタチンアナログ、抗CGRPモノクローナル抗体による、女性における脱毛症の関連性調査研究
⑥Drug-induced liver injury associated with the use of newer antiseizure medications in the elderly: an analysis of data from VigiBase.
新規抗てんかん薬による薬剤性肝障害についての分析研究
対象DB:VigiBase
Date
(PubMed追加日)